Precise In Vivo Inflammation Imaging Using In Situ Responsive Cross‐linking of Glutathione‐Modified Ultra‐Small NIR‐II Lanthanide Nanoparticles
Angewandte Chemie International Edition2018Vol. 58(7), pp. 2050–2054
Citations Over TimeTop 1% of 2018 papers
Abstract
To improve the bioimaging signal-to-noise ratio (SNR), long-term imaging capability, and decrease the potential biotoxicity, an in vivo cross-linking strategy was developed by using sub-10 nm, glutathione-modified, lanthanide nanoprobes. After administration, the nanoprobes cross-link in response to reactive oxygen species (ROS) at the inflamed area and enable the quick imaging of ROS in the second near-infrared (NIR-II) window. These nanoprobes could be rapidly excreted due to their ultra-small size. This strategy may also be applied to other ultra-small contrast agents for the precise bioimaging by in situ lesion cross-linking.
Related Papers
- → Color Tuning and White Light Emission via in Situ Doping of Luminescent Lanthanide Metal–Organic Frameworks(2013)219 cited
- → Electronegativity and structural characteristics of lanthanides(2004)41 cited
- New Opportunities for Lanthanide Luminescence(2007)
- → Complexation of lanthanide nitrates(1992)6 cited
- → Extraction of macro- and microamounts of lanthanides by D2EHPA(1990)6 cited